{
  "guideline": {
    "id": "PA166129517",
    "name": "Annotation of FDA Label for isoflurane and CACNA1S, RYR1",
    "source": "FDA",
    "version": 30,
    "url": "https://www.pharmgkb.org/labelAnnotation/PA166129517",
    "relatedChemicals": [
      {
        "id": "PA450106",
        "name": "isoflurane",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA85",
        "name": "calcium voltage-gated channel subunit alpha1 S",
        "symbol": "CACNA1S"
      },
      {
        "id": "PA34896",
        "name": "ryanodine receptor 1",
        "symbol": "RYR1"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166312623",
      "name": "Recommendation Annotation PA166312623",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450106",
          "name": "isoflurane",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452218682,
        "html": "<p>&quot;CONTRAINDICATIONS...with known or suspected genetic susceptibility to malignant hyperthermia...FORANE [isoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "RYR1": "Uncertain Susceptibility",
        "CACNA1S": "Uncertain Susceptibility"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311844",
      "name": "Recommendation Annotation PA166311844",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450106",
          "name": "isoflurane",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216043,
        "html": "<p>&quot;CONTRAINDICATIONS...with known or suspected genetic susceptibility to malignant hyperthermia...FORANE [isoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "RYR1": "No Result",
        "CACNA1S": "Malignant Hyperthermia Susceptibility"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312603",
      "name": "Recommendation Annotation PA166312603",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450106",
          "name": "isoflurane",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452218670,
        "html": "<p>&quot;CONTRAINDICATIONS...with known or suspected genetic susceptibility to malignant hyperthermia...FORANE [isoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "RYR1": "No Result",
        "CACNA1S": "Uncertain Susceptibility"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311861",
      "name": "Recommendation Annotation PA166311861",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450106",
          "name": "isoflurane",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216060,
        "html": "<p>&quot;CONTRAINDICATIONS...with known or suspected genetic susceptibility to malignant hyperthermia...FORANE [isoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "RYR1": "Uncertain Susceptibility",
        "CACNA1S": "Malignant Hyperthermia Susceptibility"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311863",
      "name": "Recommendation Annotation PA166311863",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450106",
          "name": "isoflurane",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216062,
        "html": "<p>&quot;CONTRAINDICATIONS...with known or suspected genetic susceptibility to malignant hyperthermia...FORANE [isoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "RYR1": "Malignant Hyperthermia Susceptibility",
        "CACNA1S": "Uncertain Susceptibility"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312622",
      "name": "Recommendation Annotation PA166312622",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450106",
          "name": "isoflurane",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452218681,
        "html": "<p>&quot;CONTRAINDICATIONS...with known or suspected genetic susceptibility to malignant hyperthermia...FORANE [isoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "RYR1": "Uncertain Susceptibility",
        "CACNA1S": "No Result"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311843",
      "name": "Recommendation Annotation PA166311843",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450106",
          "name": "isoflurane",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216042,
        "html": "<p>&quot;CONTRAINDICATIONS...with known or suspected genetic susceptibility to malignant hyperthermia...FORANE [isoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "RYR1": "Malignant Hyperthermia Susceptibility",
        "CACNA1S": "Malignant Hyperthermia Susceptibility"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166311862",
      "name": "Recommendation Annotation PA166311862",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA450106",
          "name": "isoflurane",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216061,
        "html": "<p>&quot;CONTRAINDICATIONS...with known or suspected genetic susceptibility to malignant hyperthermia...FORANE [isoflurane] can induce malignant hyperthermia in patients with known or suspected susceptibility based on genetic factors or family history, including those with certain inherited ryanodine receptor (RYR1) or dihydropyridine receptor (CACNA1S) variants.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "RYR1": "Malignant Hyperthermia Susceptibility",
        "CACNA1S": "No Result"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": null,
      "title": "Drugs@FDA: Drug Product FORANE (isoflurane), NDA017624, Baxter Healthcare Corporation",
      "authors": [],
      "journal": null,
      "year": -1,
      "_sameAs": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=017624"
    }
  ],
  "version": "2024-02-29-20-19"
}